Antimicrobial Resistance: – A Growing Serious Threat for Global Public Health

Year : 2026 | Volume : 17 | 02 | Page :
    By

    Hemansi N. Patil,

  • Akash S. Jain,

  • Divakar R. Patil,

  • Azam Z. Shaikh,

  • Kanhaiyalal P. Patil,

  • Hitendra S. Chaudhari,

  • S. P. Pawar,

  1. Student of Final Year B. Pharmacy, Department of Pharmacy, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India
  2. Asssistant Professor, Department of Pharmacy, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India
  3. Asssistant Professor, Department of Pharmacy, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India
  4. Asssistant Professor, Department of Pharmacy, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India
  5. Asssistant Professor, Department of Pharmacy, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India
  6. Asssistant Professor, Department of Pharmacy, P.S.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India
  7. Principle, P.G.V.P. Mandal’s College of Pharmacy, Shahada, Maharashtra, India

Abstract

Antibiotics, among the most significant discoveries of the 20th century, have prevented infectious diseases from claiming millions of lives. However, their widespread use and misuse have created strong selection pressure, enabling microbes to develop antimicrobial resistance (AMR) to many drugs. Over time, AMR has spread primarily through human-to-human contact, both within healthcare settings and in the community. It is driven by a complex interplay of healthcare and agricultural factors, including the excessive use of antibiotics in livestock feed, which significantly contributes to the emergence and spread of resistance. Antimicrobial-resistant bacteria are now increasingly common, posing a serious global public health threat. Treatment options for resistant infections are limited, leading to higher healthcare costs, as well as increased morbidity and mortality. Furthermore, the development of new antimicrobial agents has not kept pace with the growing demand. To combat AMR, coordinated global efforts are essential. Key strategies include surveillance, responsible antibiotic use, improved access to quality healthcare, and strong regulatory measures to prevent a potential post-antibiotic era.

Keywords: Antibiotics; antimicrobial resistance; mechanisms of resistance; drivers of resistance; measures to combat resistance

How to cite this article:
Hemansi N. Patil, Akash S. Jain, Divakar R. Patil, Azam Z. Shaikh, Kanhaiyalal P. Patil, Hitendra S. Chaudhari, S. P. Pawar. Antimicrobial Resistance: – A Growing Serious Threat for Global Public Health. Research and Reviews: A Journal of Pharmaceutical Science. 2026; 17(02):-.
How to cite this URL:
Hemansi N. Patil, Akash S. Jain, Divakar R. Patil, Azam Z. Shaikh, Kanhaiyalal P. Patil, Hitendra S. Chaudhari, S. P. Pawar. Antimicrobial Resistance: – A Growing Serious Threat for Global Public Health. Research and Reviews: A Journal of Pharmaceutical Science. 2026; 17(02):-. Available from: https://journals.stmjournals.com/rrjops/article=2026/view=246009


References

1. Salam, M.A.; Al-Amin, M.Y.; Salam, M.T.; Pawar, J.S.; Akhter, N.; Rabaan, A.A.; Alqumber, M.A.A. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare 2023, 11, 1946.
2. Prachi Chandrakar and Sahil Thakur. (2025). Antimicrobial Resistance: A Silent Pandemic Threatening Global Health, Economy, and The Future of Antibiotics. In Bio vet innovator magazine (Vol1, Issue 6, pp.1-9)
3. Desai V, Kumar S, Patel B, et al. (April 11, 2025) Navigating Antimicrobials and Combating Antimicrobial Resistance: Challenges, Impacts, and Strategies for Global Action.cureus 17(4):e82064.
4. Davies, J.E. Origins, Acquisition and Dissemination of Antibiotic Resistance Determinants. In Ciba Foundation Symposium 207 – Antibiotic Resistance: Origins, Evolution, Selection and Spread; John Wiley & Sons, Ltd; pp. 15–35.
5. Doma, A.O.; Popescu, R.; Mitulețu, M.; Muntean, D.; Dégi, J.; Boldea, M.V.; Radulov, I.; Dumitrescu, E, Muselin, F.; Puvača, N.; et al. Comparative Evaluation of QnrA, QnrB, and QnrS Genes in Enterobacteriaceae Ciprofloxacin-Resistant Cases, in Swine Units and a Hospital from Western Romania. Antibiotics 2020, 9,698.
6. Chelo-In Kang, and Jae-Hoon Song.Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implication. Infect Chemother. (2013); 45(1):22-31.
7. .Samreen, Iqbal Ahmad, Hesham A.Malak, Hussein H. Abulreesh. Environmental antimicrobial resistance and its drivers: a potential threat to Public health. Journal of Global Antimicrobial Resistance-27 (2021)101-111.
8. Zaman, S.B.; Hussain, M.A.; Nye, R.; Mehta, V.; Mamun, K.T.; Hossain, N. A Review on Antibiotic Resistance: Alarm Bells are ringing. Cureus 2017, 9, e1403.
9. Kumar S and Singh BR (2013). An overview of mechanisms and emergence of antimicrobials drug resistance. Adv. Anim. Vet. Sci. 1 (2S): 7 – 1.
10. Rana H. Raheema. A Review of the Superbug Crisis. Wasit Journal for Pure Science. Vol. 4 No. 2 (2025) p. 76-84.
11. Noortje G. Godijk1, Martin C. J. Bootsma, and Marc J. M. Bonten. Transmission routes of antibiotic resistant bacteria: a systematic review. Godijk et al. BMC Infectious Diseases (2022) 22.482.
12. Yosra A. Helmy , Khaled Taha-Abdelaziz , Hanan Abd El-Halim Hawwas, Soumya Ghosh Samar Sami AlKafaas , Mohamed M. M.Moawad6,Essa M.Saied and AsmaaM.M.Mawad. Antimicrobial Resistance and Recent Alternatives to Antibiotics for the Control of Bacterial Pathogens with an Emphasis on Foodborne Pathogens. Antibiotics 2023, 12, 274.
13. Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol. 2018 Jun 26; 4(3):482-501.
14. Choi, U.; Lee, C.R. Distinct Roles of Outer Membrane Porins in Antibiotic Resistance and Membrane Integrity in Escherichia coli. Front. Microbiol. 2019, 10, 953.
15. Dutt, Y.; Dhiman, R.; Singh, T.; Vibhuti, A.; Gupta, A.; Pandey, R.P.; Raj, V.S.; Chang, C.M.; Priyadarshini, A. The Association between Biofilm Formation and Antimicrobial Resistance with Possible Ingenious Bio-Remedial Approaches. Antibiotics 2022, 11, 930.
16. Ashley, R.E.; Dittmore, A.; McPherson, S.A.; Turnbough, C.L., Jr.; Neuman, K.C.; Osheroff, N. Activities of gyrase and topoiso merase IV on positively supercoiled DNA. Nucleic Acids Res. 2017, 45, 9611–9624.
17. Saha, M.; Sarkar, A. Review on Multiple Facets of Drug Resistance: A Rising Challenge in the 21st Century. J. Xenobiotics 2021, 11, 197–214.
18. Blair, J.M.; Webber, M.A.; Baylay, A.J.; Ogbolu, D.O.; Piddock, L.J. Molecular mechanisms of antibiotic resistance. Nat. Reviews. Microbiol. 2015, 13, 42–51.
19. Nikaido, H.; Pagès J.M. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria. FEMS Microbiol. Rev. 2012, 36, 340–363.
20. Blair, J.M.; Richmond, G.E.; Piddock, L.J. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance. Future Microbiol. 2014, 9, 1165–1177
21. Susan Ekuri. Antimicrobial Resistance: Implementing an Effective Response for a Growing Global Health Threat. Premier Journal of Public Health 2024;1:100017.
22. Chinmoyee Deori, Tonushyam Sonowal, Monalisha Das. Antimicrobial resistance: A looming threat to public health and global well being. Indian Journal of Community and Family Medicine | Volume 10 | Issue 1 2024.
23. Gordon SB, Chaponda M, Walsh AL, Whitty CJ, Gordon MA, Machili CE, et al. Pneumococcal disease in HIV-infected Malawian adults: Acute mortality and long-term survival. AIDS 2002; 16:1409-17.
24. VanBoeckel, T.P.; Brower, C.; Gilbert, M.; Grenfell, B.T.; Levin, S.A.; Robinson, T.P.; Teillant, A.; Laxminarayan, R. Global trends in antimicrobial use in food animals. Proc. Natl. Acad. Sci. USA 2015, 112, 5649–5654.
25. Pulia, M.; Kern, M.; Schwei, R.J.; Shah, M.N.; Sampene, E.; Crnich, C.J. Comparing appropriateness of antibiotics for nursing home residents by setting of prescription initiation: A cross-sectional analysis. Antimicrob. Resist. Infect. Control 2018, 7, 74
26. Woolhouse M, Waugh C, Perry MR, Nair H. Global disease burden due to antibiotic resistance – state of the evidence. J Glob Health. 2016 Jun; 6(1):010306.
27. Chang, Q.; Wang, W.; Regev-Yochay, G.; Lipsitch, M.; Hanage, W.P. Antibiotics in agriculture and the risk to human health: How worried should we be? Evol. Appl. 2015, 8, 240–247.
28. Tang, K.W.K.; Millar, B.C.; Moore, J.E. Antimicrobial Resistance (AMR). Br. J. Biomed. Sci. 2023, 80, 11387.
29. Sariola, S.; Humanities, A.B.-M.; 2022, undefined In Critique of Anthropocentrism: A More-than-Human Ethical Framework for Antimicrobial Resistance. mh.bmj.com 2022, 48, 16.
30. Carter, R.R.; Sun, J.; Jump, R.L. A Survey and Analysis of the American Public’s Perceptions and Knowledge about Antibiotic Resistance. Open Forum Infect. Dis. 2016, 3, ofw112.
31. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of Bacterial Antimicrobial Resistance in 2019: a Systematic Analysis. Lancet (2022) 399(10325):629–55.
32. Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019 Jan; 17(1):3(2019)
33. Pulingam, T.; Parumasivam, T.; A.G.-E.J. of; 2022, undefined Antimicrobial Resistance: Prevalence, Economic Burden, Mechanisms of Resistance and Strategies to Overcome. Elsevier. Volume 170, 1 March 2022, 106103.
34. Eric Utta, and Charles Wells. The global response to the threat of antimicrobial resistance and the important role of vaccines. Pharmaceuticals Policy and Law 18 (2016) 179–197.
35. Tacconelli E, Pezzani MD. Public health burden of antimicrobial resistance in Europe. Lancet Infect Dis. 2019 Jan; 19(1):4-6. Epub 2018 Nov 5.
36. Dunachie, S.; Day, N.; Microbiology, C.D. C.O. in; 2020, undefined The Challenges of Estimating the Human Global Burden of Disease of Antimicrobial Resistant Bacteria. Elsevier. 2020, 57:95–101.
37. Naylor NR, Atun R, Zhu N, Kulasabanathan K, Silva S, Chatterjee A, Knight GM, Robotham JV. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob Resist Infect Control. 2018 Apr 25; 7:58.
38. Finlay, B.; Conly, J.; Coyte, P.; Dillon, J.; Douglas, G. When Antibiotics Fail: The Expert Panel on the Potential Socio Economic Impacts of Antimicrobial Resistance in Canada. 2019.
39. De Oliveira, D.M.P.; Forde, B.M.; Kidd, T.J.; Harris, P.N.A.; Schembri, M.A.; Beatson, S.A.; Paterson, D.L.; Walker, M.J. Antimicrobial Resistance in ESKAPE Pathogens. Clin. Microbiol. Rev. 2020, May 13; 33(3)
40. Murugaiyan, J.; Kumar, P.; Rao, G.; Antibiotics, K.I.-; 2022, undefined Progress in Alternative Strategies to Combat Antimicrobial Resistance: Focus on Antibiotics. Antibiotics 2022, 11, 200.
41. Lin, T.Z.; Jayasvasti, I.; Tiraphat, S.; Pengpid, S.; Jayasvasti, M.; Borriharn, P. The Predictors Influencing the Rational Use of Antibiotics among Public Sector: A Community-Based Survey in Thailand. Drug Healthc. Patient Saf. 2022, 14, 27–36.
42. Plachouras, D.; Lepape, A.; Suetens, C. ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units. Intensive Care Med. 2018, 44, 2216–2218.
43. Prabhu, K.; Rao, S.; Rao, V. Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J. Lab. Physicians 2011, 3, 25–27.
44. Alcala, L.; Alonso, C.A.; Simon, C.; Gonzalez-Esteban, C.; Oros, J.; Rezusta, A.; Ortega, C.; Torres, C. Wild Birds, Frequent Carriers of Extended-Spectrum-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types. Microb. Ecol. 2016, 72, 861–869.
45. Carvalho, I.; Tejedor-Junco, M.T.; González-Martín, M.; Corbera, J.A.; Suárez-Pérez, A.; Silva, V.; Igrejas, G.; Torres, C.; Poeta, P. Molecular Diversity of Extended-Spectrum β-lactamase-producing Escherichia coli from vultures in Canary Islands. Environ. Microbiol. Rep. 2020, 12, 540–547.
46. Brown, N.M.; Goodman, A.L.; Horner, C.; Jenkins, A.; Brown, E.M. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): Updated guidelines from the UK. JAC Antimicrob. Resist. 2021, Feb 3; 3(1):dlaa114.
47.Salgado-Caxito, M.; Benavides, J.A.; Adell, A.D.; Paes, A.C.; Moreno-Switt, A.I. Global prevalence and molecular characterization of extended-spectrum-lactamase producing-Escherichia coli in dogs and cats A scoping review and meta-analysis. One Health 2021, 12, 100236.
48. Jans, C.; Merz, A.; Johler, S.; Younan, M.; Tanner, S.A.; Kaindi, D.W.M.; Wangoh, J.; Bonfoh, B.; Meile, L.; Tasara, T. East and West African milk products are reservoirs for human and livestock-associated Staphylococcus aureus. Food Microbiol. 2017, 65, 64–73.
49. Mellmann, A.; Bletz, S.; Böking, T.; Kipp, F.; Becker, K.; Schultes, A.; Prior, K.; Harmsen, D. Real-time genome sequencing of the beef production chain. Appl. Environ. Microbiol. 2016, 82, 2433–2443.
50. Rohde, L.E.; Clausell, N.; Ribeiro, J.P.; Goldraich, L.; Netto, R.; William Dec, G.; DiSalvo, T.G.; Polanczyk, C.A. Health outcomes in decompensated congestive heart failure: A comparison of tertiary hospitals in Brazil and United States. Int. J. Cardiol. 2005, 102, 71–77.
51. Hossain, M.E.; Kabir, M.A.; Zheng, L.; Swain, D.L.; McGrath, S.; Medway, J. A systematic review of machine learning techniques for cattle identification: Datasets, methods and future directions. Artificial Intelligence in Agriculture. (2022), 6, 138–155.
52. Control A Global Governance to Tackle Antimicrobial Resistance: The Way Forward. [(Accessed on 4 June 2023)].
53. Leung E, Weil DE, Raviglione M, Nakatani H. World Health Organization. World Health Day Antimicrobial Resistance Technical Working Group. The WHO policy package to combat antimicrobial resistance. Bull World Health Organ. 2011; 89(5):390-2
54. WHO Antibiotic resistance. Available online: https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance (accessed on 12 November 2022).
55. WHO Assessing Non-Prescription and Inappropriate Use of Antibiotics Report on Survey.Availableonline:https://apps.who.int/iris/bitstream/handle/10665/312306/9789289054089eng.pdf? Sequence=1&isAllowed=y (accessed on 4 June 2023).
56. WHO Infection Prevention and Control. Available online: https://www.who.int/teams/integrated-health-services/infection prevention-control (accessed on 12 November 2022).
57. Pinto Ferreira, J.; Battaglia, D.; Dorado García, A.; Tempelman, K.; Bullon, C.; Motriuc, N.; Caudell, M.; Cahill, S.; Song, J.; LeJeune, J. Achieving Antimicrobial Stewardship on the Global Scale: Challenges and Opportunities. Microorganisms 2022, 10, 1599.
58. Aidara-Kane, A.; Angulo, F.J.; Conly, J.M.; Minato, Y.; Silbergeld, E.K.; McEwen, S.A.; Collignon, P.J. World Health Organization (WHO)guidelines on use of medically important antimicrobials in food-producing animals. Antimicrob Resis Control 2018, 7, 7.
59. Mitchell, J.; Cooke, P.; Ahorlu, C.; Arjyal, A.; Baral, S.; Carter, L.; Dasgupta, R.; Fieroze, F.; Fonseca-Braga, M.; Huque, R.; et al. Community engagement: The key to tackling Antimicrobial Resistance (AMR) across a One Health context? Glob. Public Health 2022, 17, 2647–2664.
60. Amaning Danquah, C.; Minkah, P.A.B.; Osei Duah Junior, I.; Amankwah, K.B.; Somuah, S.O. Antimicrobial Compounds from Microorganisms. Antibiotics 2022, 11, 285.
61. Brives, C.; Pourraz, J. Phage therapy as a potential solution in the fight against AMR: Obstacles and possible futures. Palgrave Commun. 2020, 6, 100.
62. Margarita Corrales, Avelina Fernández, Jung H. Han. Antimicrobial Packaging Systems. Innovations in Food Packaging (Second Edition). 2014, Pages 133-170.
63. WHO One Health Initiative. Available online: https://www.who.int/teams/one-health-initiative (accessed on 29 June 2023).
64. VanCamp, P.J.; Haslam, D.B.; Porollo, A. Prediction of Antimicrobial Resistance in Gram-Negative Bacteria from Whole-Genome Sequencing Data. Front. Microbiol. 2020, 11, 1013.

 

 

 

 

 

 

 

 

 

 

 

Ahead of Print Subscription Original Research
Volume 17
02
Received 19/04/2026
Accepted 03/06/2026
Published 04/06/2026
Publication Time 46 Days
1

Login


My IP

PlumX Metrics